STAT3 mediates protection from liver inflammation after partial hepatectomy

Cellular Physiology and Biochemistry

Volumn 23, Issue 4-6, 2009, Pages 379-386

  Xu, Yan ^a,b   Feng, Dechun ^a,b   Wang, Ying ^a   Luo, Qingqiong ^a   Xu, Lingyun ^a,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c Chinese Academy of Sciences ^*  (China)

Author keywords

ConA; Hepatoprotection; Immune challenge; Liver regeneration; STAT3

Indexed keywords

ALANINE AMINOTRANSFERASE; CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DOWN REGULATION; HEPATITIS; IMMUNE RESPONSE; INTERFERON PRODUCTION; LIVER INJURY; LIVER PROTECTION; LIVER REGENERATION; MALE; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

MUS;

EID: 66749165268     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218184     Document Type: Article

References (39)

1. Fausto N, Laird AD, Webber EM: Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. Faseb J 1995;9:1527-1536.
2. Michalopoulos GK, DeFrances MC: Liver regeneration. Science 1997;276:60-66.
3. White SA, Al-Mukhtar A, Lodge J P, Pollard SG: Progress in living donor liver transplantation. Transplant Proc 2004;36:2720-2726.
4. Higgin G AR: Experimental pathology of the liver. I: Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931;12:186-202.
5. van de Kerkhove MP, Hoekstra R, van Gulik TM, Chamuleau RA: Large animal models of fulminant hepatic failure in artificial and bioartificial liver support research. Biomaterials 2004;25:1613-1625.
6. Taub R: Liver regeneration: From myth to mechanism. Nat Rev Mol Cell Biol 2004;5:836-847.
7. Blindenbacher A, Wang X, Langer I, Savino R, Terracciano L, Heim MH: Interleukin 6 is important for survival after partial hepatectomy in mice. Hepatology 2003;38:674-682.
8. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R: Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379-1383.
9. Yamada Y, Kirillova I, Peschon JJ, Fausto N: Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type i tumor necrosis factor receptor. Proc Natl Acad Sci U S A 1997;94:1441-1446.
10. Ledda-Columbano GM, Curto M, Piga R, Zedda AI, Menegazzi M, Sartori C, Shinozuka H, Bluethmann H, Poli V, Ciliberto G, Columbano A: In vivo hepatocyte proliferation is inducible through a tnf and il-6-independent pathway. Oncogene 1998;17:1039-1044.
11. Pediaditakis P, Lopez-Talavera JC, Petersen B, Monga SP, Michalopoulos GK: The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat. Hepatology 2001;34:688-693.
12. Shimizu M, Hara A, Okuno M, Matsuno H, Okada K, Ueshima S, Matsuo O, Niwa M, Akita K, Yamada Y, Yoshimi N, Uematsu T, Kojima S, Friedman SL, Moriwaki H, Mori H: Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: Impaired activation of hepatocyte growth factor after fas-mediated massive hepatic apoptosis. Hepatology 2001;33:569-576.
13. Jones DE, Jr., Tran-Patterson R, Cui DM, Davin D, Estell KP, Miller DM: Epidermal growth factor secreted from the salivary gland is necessary for liver regeneration. Am J Physiol 1995;268:G872-878.
14. Lambotte L, Saliez A, Triest S, Maiter D, Baranski A, Barker A, Li B: Effect of sialoadenectomy and epidermal growth factor administration on liver regeneration after partial hepatectomy. Hepatology 1997;25:607-612.
15. Iimuro Y, Nishiura T, Hellerbrand C, Behrns KE, Schoonhoven R, Grisham JW, Brenner DA: Nfkappab prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest 1998;101:802-811.
16. Moh A, Iwamoto Y, Chai GX, Zhang SS, Kano A, Yang DD, Zhang W, Wang J, Jacoby JJ, Gao B, Flavell RA, Fu XY: Role of stat3 in liver regeneration: Survival, DNA synthesis, inflammatory reaction and liver mass recovery. Lab Invest 2007;87:1018-1028.
17. Stepniak E, Ricci R, Eferl R, Sumara G, Sumara I, Rath M, Hui L, Wagner EF: C-jun/ap-1 controls liver regeneration by repressing p53/p21 and p38 mapk activity. Genes Dev 2006;20:2306-2314.
18. Steer CJ: Liver regeneration. Faseb J 1995;9:1396-1400.
19. Takehara T, Hayashi N, Mita E, Kanto T, Tatsumi T, Sasaki Y, Kasahara A, Hori M: Delayed fas-mediated hepatocyte apoptosis during liver regeneration in mice: Hepatoprotective role of tnf alpha. Hepatology 1998;27:1643-1651.
20. Kita H, Mackay IR, Van De Water J, Gershwin ME: The lymphoid liver: Considerations on pathways to autoimmune injury. Gastroenterology 2001;120:1485-1501.
21. Heneghan MA, McFarlane IG: Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 2002;35:7-13.
22. Bogdanos DP, Mieli-Vergani G, Vergani D: Virus, liver and autoimmunity. Dig Liver Dis 2000;32:440-446.
23. Rehermann B, Chisari FV: Cell mediated immune response to the hepatitis c virus. Curr Top Microbiol Immunol 2000;242:299-325.
24. Furrer K, Tian Y, Pfammatter T, Jochum W, El-Badry AM, Graf R, Clavien PA: Selective portal vein embolization and ligation trigger different regenerative responses in the rat liver. Hepatology 2008;47:1615-1623.
25. Kremer M, Perry AW, Milton RJ, Rippe RA, Wheeler MD, Hines IN: Pivotal role of smad3 in a mouse model of t cell-mediated hepatitis. Hepatology 2008;47:113-126.
26. Tiegs G, Hentschel J, Wendel A: A t cell-dependent experimental liver injury in mice inducible by concanavalin a. J Clin Invest 1992;90:196-203.
27. Trautwein C, Rakemann T, Brenner DA, Streetz K, Licato L, Manns MP, Tiegs G: Concanavalin a-induced liver cell damage: Activation of intracellular pathways triggered by tumor necrosis factor in mice. Gastroenterology 1998;114:1035-1045.
28. Hong F, Jaruga B, Kim WH, Radaeva S, El-Assal ON, Tian Z, Nguyen VA , Gao B: Opposing roles of stat1 and stat3 in t cell-mediated hepatitis: Regulation by socs. J Clin Invest 2002;110:1503-1513.
29. Li W, Liang X, Kellendonk C, Poli V, Taub R: Stat3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 2002;277:28411-28417.
30. Klein C, Wustefeld T, Assmus U, Roskams T, Rose-John S, Muller M, Manns M P, Ernst M, Trautwein C: The il-6-gp130-stat3 pathway in hepatocytes triggers liver protection in t cell-mediated liver injury. J Clin Invest 2005;115:860-869.
31. Radaeva S, Sun R, Pan HN, Hong F, Gao B: Interleukin 22 (il-22) plays a protective role in t cell-mediated murine hepatitis: Il-22 is a survival factor for hepatocytes via stat3 activation. Hepatology 2004;39:1332-1342.
32. Kawamura H, Govindarajan S, Aswad F, Machida K, Lai MM, Sung VM, Dennert G: Hcv core expression in hepatocytes protects against autoimmune liver injury and promotes liver regeneration in mice. Hepatology 2006;44:936-944.
33. Seidman L: Responsible health insurance revisited: Pouring liberal wine into a conservative bottle. Inquiry 2005;42:118-128.
34. Hines IN, Kremer M, Isayama F, Perry AW, Milton RJ, Black AL, Byrd CL, Wheeler MD: Impaired liver regeneration and increased oval cell numbers following t cell-mediated hepatitis. Hepatology 2007;46:229-241.
35. Blaskovich MA, Sun J, Cantor A, Turkson J, Jove R, Sebti SM: Discovery of jsi-124 (cucurbitacin i), a selective janus kinase/ signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res 2003;63:1270-1279.
36. Nefedova Y, Nagaraj S, Rosenbauer A, Muro-Cacho C, Sebti SM, Gabrilovich DI: Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway. Cancer Res 2005;65:9525-9535.
37. Molavi O, Ma Z, Hamdy S, Lai R, Lavasanifar A, Samuel J: Synergistic antitumor effects of cpg oligodeoxynucleotide and stat3 inhibitory agent jsi-124 in a mouse melanoma tumor model. Immunol Cell Biol 2008;86:506-514.
38. Horiguchi N, Wang L, Mukhopadhyay P, Park O, Jeong WI, Lafdil F, Osei-Hyiaman D, Moh A, Fu XY, Pacher P, Kunos G, Gao B: Cell type-dependent pro-and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. Gastroenterology 2008;134:1148-1158.
39. Streetz KL, Wustefeld T, Klein C, Kallen KJ, Tronche F, Betz UA, Schutz G, Manns MP, Muller W, Trautwein C: Lack of gp130 expression in hepatocytes promotes liver injury. Gastroenterology 2003;125:532-543.